Form 8-K - Current report:
SEC Accession No. 0001559053-25-000022
Filing Date
2025-05-08
Accepted
2025-05-08 16:10:38
Documents
15
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20250508.htm   iXBRL 8-K 32175
2 EX-99.1 exhibit991q12025earningsre.htm EX-99.1 82472
6 GRAPHIC - LOGO prothenalogoa.jpg GRAPHIC 15694
  Complete submission text file 0001559053-25-000022.txt   277997

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20250508.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20250508_lab.xml EX-101.LAB 23251
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20250508_pre.xml EX-101.PRE 13538
17 EXTRACTED XBRL INSTANCE DOCUMENT prta-20250508_htm.xml XML 2933
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 25926170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)